Related references
Note: Only part of the references are listed.Distinct Regulation of σ1 Receptor Multimerization by Its Agonists and Antagonists in Transfected Cells and Rat Liver Membranes
Weimin Conrad Hong
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors
Haider Abbas et al.
FRONTIERS IN PHARMACOLOGY (2020)
Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression
James M. Brimson et al.
SCIENTIFIC REPORTS (2020)
Additional Safety and Exploratory Efficacy Data at 48 and 60 Months from Open-HART, an Open-Label Extension Study of Pridopidine in Huntington Disease
Andrew McGarry et al.
JOURNAL OF HUNTINGTONS DISEASE (2020)
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Ralf Reilmann et al.
LANCET NEUROLOGY (2019)
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease
Veronica Francardo et al.
NEUROTHERAPEUTICS (2019)
Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
Ariel Ionescu et al.
CELL DEATH & DISEASE (2019)
Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo
Maximilian G. Christ et al.
CELLS (2019)
Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor
Daniel Ryskamp et al.
NEUROBIOLOGY OF DISEASE (2019)
Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease A Phase 2 Randomized Clinical Trial
Lon S. Schneider et al.
JAMA NEUROLOGY (2019)
A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset
Rosalia Pascual et al.
FRONTIERS IN PHARMACOLOGY (2019)
Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Daniel A. Ryskamp et al.
FRONTIERS IN NEUROSCIENCE (2019)
Mutational Analysis of Sigma-1 Receptor's Role in Synaptic Stability
Daniel A. Ryskamp et al.
FRONTIERS IN NEUROSCIENCE (2019)
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H. Johnston et al.
MOVEMENT DISORDERS (2019)
Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors
Eugen Brailoiu et al.
CELL REPORTS (2019)
Olfactory Dysfunction Predicts Subsequent Dementia in Older US Adults
Dara R. Adams et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease
Helene Hall et al.
ALZHEIMERS & DEMENTIA (2018)
Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
Rebecca Kusko et al.
MOLECULAR NEURODEGENERATION (2018)
Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines
James M. Brimson et al.
NEUROTOXICITY RESEARCH (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage
Hiroki Abe et al.
SCIENCE (2018)
Cocaine Effects on Dopaminergic Transmission Depend on a Balance between Sigma-1 and Sigma-2 Receptor Expression
David Aguinaga et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
The sigma-2 (sigma-2) receptor: a review of recent patent applications: 2013-2018
Benjamin E. Blass et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Structural basis for σ1 receptor ligand recognition
Hayden R. Schmidt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors
Kazuki Terada et al.
PLOS ONE (2018)
Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex
Aladdin Riad et al.
SCIENTIFIC REPORTS (2018)
Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis
Cecilia Rajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease
Bitna Yi et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Laughter, crying and sadness in ALS
Nimish J. Thakore et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra
Juan Hong et al.
NEUROBIOLOGY OF AGING (2017)
The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
Daniel Ryskamp et al.
NEUROBIOLOGY OF DISEASE (2017)
Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
Richard Smith et al.
NEUROTHERAPEUTICS (2017)
Identification of the gene that codes for the σ2 receptor
Assaf Alon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology
Martino Bertoni et al.
SCIENTIFIC REPORTS (2017)
Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
Marta Garcia-Miralles et al.
JCI INSIGHT (2017)
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins
Alice Dreser et al.
CELL DEATH AND DIFFERENTIATION (2017)
Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments
Tangui Maurice
BEHAVIOURAL BRAIN RESEARCH (2016)
Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS
Seiji Watanabe et al.
EMBO MOLECULAR MEDICINE (2016)
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
Michal Geva et al.
HUMAN MOLECULAR GENETICS (2016)
Crystal structure of the human σ1 receptor
Hayden R. Schmidt et al.
NATURE (2016)
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
Charles P. Taylor et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease
Khanh Q. Nguyen et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Aberrant Subcellular Dynamics of Sigma-1 Receptor Mutants Underlying Neuromuscular Diseases
Adrian Y. C. Wong et al.
MOLECULAR PHARMACOLOGY (2016)
Sigma-1 receptor is a molecular target for novel neuroprotectant T-817MA
Takeaki Yano et al.
Alzheimers & Dementia (2015)
The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands
Ashish K. Mishra et al.
BIOCHEMICAL JOURNAL (2015)
High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis
B. Oxombre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function
Takashi Uehara et al.
CURRENT NEUROPHARMACOLOGY (2015)
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia A Randomized Clinical Trial
Jeffrey L. Cummings et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
Manuel de Lera Ruiz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
Timur A. Mavlyutov et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease
Yasuo Miki et al.
NEUROBIOLOGY OF DISEASE (2015)
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
Kristoffer Sahlholm et al.
PSYCHOPHARMACOLOGY (2015)
Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model
Valentine Lahmy et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Functional assays to define agonists and antagonists of the sigma-2 receptor
Chenbo Zeng et al.
ANALYTICAL BIOCHEMISTRY (2014)
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
Veronica Francardo et al.
BRAIN (2014)
Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells
Tamaki Ishima et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Effects of Dextromethorphan on Glial Cell Function: Proliferation, Maturation, and Protection from Cytotoxic Molecules
Robert P. Lisak et al.
GLIA (2014)
The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases
Pilar Sanchez-Blazquez et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
A Direct Interaction between the Sigma-1 Receptor and the hERG Voltage-gated K+ Channel Revealed by Atomic Force Microscopy and Homogeneous Time-resolved Fluorescence (HTRF®)
Dilshan Balasuriya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands
Katarzyna A. Gromek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
NMDA Receptors Are Upregulated and Trafficked to the Plasma Membrane after Sigma-1 Receptor Activation in the Rat Hippocampus
Mohan Pabba et al.
JOURNAL OF NEUROSCIENCE (2014)
Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield
Yusaku Takamura et al.
NEUROBIOLOGY OF AGING (2014)
Neuroprotective effects of the Sigma-1 receptor (SIR) agonist PRE-084, in a mouse model of moter neuron disease not linked to SOD1 mutation
Marco Peviani et al.
NEUROBIOLOGY OF DISEASE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ModBase, a database of annotated comparative protein structure models and associated resources
Ursula Pieper et al.
NUCLEIC ACIDS RESEARCH (2014)
Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
Nicholas J. Izzo et al.
PLOS ONE (2014)
Olfactory Dysfunction Predicts 5-Year Mortality in Older Adults
Jayant M. Pinto et al.
PLOS ONE (2014)
The neuroprotective and neurotrophic agent T-817MA for Alzheimer’s disease: Randomized, double-blind, placebo-controlled proof-of-concept trial outcomes
Lon Schneider et al.
Alzheimers & Dementia (2013)
Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders
Werner J. Geldenhuys et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis
J. Prause et al.
HUMAN MOLECULAR GENETICS (2013)
A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's Disease
Karl Kieburtz et al.
MOVEMENT DISORDERS (2013)
Blockade of Tau Hyperphosphorylation and Aβ1-42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer's Disease
Valentine Lahmy et al.
NEUROPSYCHOPHARMACOLOGY (2013)
LACK OF SIGMA-1 RECEPTOR EXACERBATES ALS PROGRESSION IN MICE
T. A. Mavlyutov et al.
NEUROSCIENCE (2013)
Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers
Gemma Navarro et al.
PLOS ONE (2013)
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions
Benjamin Rix Brooks et al.
PLOS ONE (2013)
Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway
A. Hyrskyluoto et al.
CELL DEATH & DISEASE (2013)
Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression
Koji Ito et al.
CARDIOVASCULAR RESEARCH (2012)
The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements
Arindam Pal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Synergistic Effects of Antidementia Drugs on Spatial Learning and Recall in the APP23 Transgenic Mouse Model of Alzheimer's Disease
Katharina L. Neumeister et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period
Takashi Uehara et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 Receptors
Tamaki Ishima et al.
PLOS ONE (2012)
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Michiko Fujimoto et al.
SYNAPSE (2012)
The sigma-1 receptor: roles in neuronal plasticity and disease
Said Kourrich et al.
TRENDS IN NEUROSCIENCES (2012)
Compromising σ-1 Receptors at the Endoplasmic Reticulum Render Cytotoxicity to Physiologically Relevant Concentrations of Dopamine in a Nuclear Factor-κB/Bcl-2-Dependent Mechanism: Potential Relevance to Parkinson's Disease
Tomohisa Mori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels
Molly Johannessen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
Amr Al-Saif et al.
ANNALS OF NEUROLOGY (2011)
T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice
Tetsuo Fukushima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
Karsten Ruscher et al.
BRAIN (2011)
Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor
J. M. Brimson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Energy deficit in Huntington disease: why it matters
Fanny Mochel et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Sigma Receptor Agonist 2-(4-Morpholinethyl) 1 Phenylcyclohexanecarboxylate (Pre084) Increases GDNF and BiP Expression and Promotes Neuroprotection after Root Avulsion Injury
Clara Penas et al.
JOURNAL OF NEUROTRAUMA (2011)
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
Justo Garcia de Yebenes et al.
LANCET NEUROLOGY (2011)
Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
Jinbin Xu et al.
NATURE COMMUNICATIONS (2011)
Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect
Erik P. Pioro et al.
ANNALS OF NEUROLOGY (2010)
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
Ian Hindmarch et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
Yuxiang Xie et al.
JOURNAL OF NEUROSCIENCE (2010)
Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease
Marta Martinez-Vicente et al.
NATURE NEUROSCIENCE (2010)
THE SIGMA-1 RECEPTOR IS ENRICHED IN POSTSYNAPTIC SITES OF C-TERMINALS IN MOUSE MOTONEURONS. AN ANATOMICAL AND BEHAVIORAL STUDY
T. A. Mavlyutov et al.
NEUROSCIENCE (2010)
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Tsung-Ping Su et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Sigma-1 receptor knockout mice display a depressive-like phenotype
Valentina Sabino et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-β peptide
Tatsuo Kimura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
SELECTIVE SIGMA RECEPTOR AGONIST 2-(4-MORPHOLINETHYL)1-PHENYLCYCLOHEXANECARBOXYLATE (PRE084) PROMOTES NEUROPROTECTION AND NEURITE ELONGATION THROUGH PROTEIN KINASE C (PKC) SIGNALING ON MOTONEURONS
M. -S. Guzman-Lenis et al.
NEUROSCIENCE (2009)
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Dominique Fontanilla et al.
SCIENCE (2009)
Low density of sigma1 receptors in early Alzheimer's disease
Masahiro Mishina et al.
ANNALS OF NUCLEAR MEDICINE (2008)
On the mechanism of antidepressant-like action of berberine chloride
Shrinivas K. Kulkarni et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor
Ashish Dhir et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Chronic treatment with a selective ligand for the sigma-1 receptor chaperone, SA4503, up-regulates BDNF protein levels in the rat hippocampus
Kazue Kikuchi-Utsumi et al.
NEUROSCIENCE LETTERS (2008)
Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways
Tomoko Nishimura et al.
PLOS ONE (2008)
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: Role of sigma-1 receptors and IP3 receptors
Tamaki Ishima et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines
Christopher P. Palmer et al.
CANCER RESEARCH (2007)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Novel sigma (σ) receptor agonists produce antidepressant-like effects in mice
Jiajia Wang et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease
Maria Laura Bolognesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Donepezil potentiates nerve growth factor-induced neurite outgrowth in PC12 cells
Toru Oda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy
Chenbo Zeng et al.
CANCER RESEARCH (2007)
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine
Ashish Dhir et al.
NEUROSCIENCE LETTERS (2007)
The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus
Marzia Martina et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats
Phuong Thi Hong Nguyen et al.
HIPPOCAMPUS (2007)
The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor
J. Meunier et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant Fluoxetine treatment
Boldizsar Czeh et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions
Raffaella Molteni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release
Y Yagasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo
Ursula Unterberger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia
C Kakiuchi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: Implication for drug abuse
T Hayashi et al.
LIFE SCIENCES (2005)
Function of sigma1 receptors in Parkinson's disease
M Mishina et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Neuroprotective effects of sigma-I receptor agonists against beta-amyloid-induced toxicity
A Marrazzo et al.
NEUROREPORT (2005)
The unfolded protein response is activated in Alzheimer's disease
JJM Hoozemans et al.
ACTA NEUROPATHOLOGICA (2005)
Antidepressant treatment of psychotic major depression:: Potential role of the σ receptor
SM Stahl
CNS SPECTRUMS (2005)
In vivo imaging of muscarinic receptors in the aging female brain with (R,R) [123I]-I-QNB and single photon emission tomography
R Norbury et al.
EXPERIMENTAL GERONTOLOGY (2005)
Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus
T Hajszan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine
M Peeters et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1-40) protein
A Urani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Induction of neuronal death by ER stress in Alzheimer's disease
T Katayama et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2004)
From magic bullets to designed multiple ligands
R Morphy et al.
DRUG DISCOVERY TODAY (2004)
Cellular toxicity of polyglutamine expansion proteins: Mechanism of transcription factor deactivation
G Schaffar et al.
MOLECULAR CELL (2004)
Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise
AA Russo-Neustadt et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes
D Gebreselassie et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Clinical trials with sigma ligands
HP Volz et al.
PHARMACOPSYCHIATRY (2004)
Neuropharmacology of the anxiolytic drug opripramol, a sigma site ligand
WE Müller et al.
PHARMACOPSYCHIATRY (2004)
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat
M Kodamo et al.
BIOLOGICAL PSYCHIATRY (2004)
Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation
T Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cell proliferation in adult hippocampus is decreased by inescapable stress: Reversal by fluoxetine treatment
JE Malberg et al.
NEUROPSYCHOPHARMACOLOGY (2003)
An increase of sigma1 receptors in the aged monkey brain
K Kawamura et al.
NEUROBIOLOGY OF AGING (2003)
Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells
T Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor
Y Sagi et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Disruption of androgen regulation in the prostate by the environmental contaminant hexachlorobenzene
JL Ralph et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Nerve growth factor-induced neurite sprouting in PC12 cells involves σ-1 receptors:: Implications for antidepressants
M Takebayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The antidepressant-like effect induced by the sigma1 (σ1) receptor agonist igmesine involves modulation of intracellular calcium mobilization
A Urani et al.
PSYCHOPHARMACOLOGY (2002)
The sigma receptor as a ligand-regulated auxiliary potassium channel subunit
E Aydar et al.
NEURON (2002)
Greater loss of 5-HT2A receptors in midlife than in late life
YI Sheline et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
The interaction between neuroactive steroids and the σ1 receptor function:: behavioral consequences and therapeutic opportunities
T Maurice et al.
BRAIN RESEARCH REVIEWS (2001)
Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands
JE Bermack et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Age-related reduction of extrastriatal dopamine D2 receptor measured by PET
M Inoue et al.
LIFE SCIENCES (2001)
The selective σ2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression
C Sánchez et al.
BEHAVIOURAL PHARMACOLOGY (2000)
Share Paper
